"the reality is the entire company is now worth significantly less..."
KSD, you just indicated either a lack of knowledge of basic valuation, or are being deliberately misleading (you choose).
Your statement refers to the firm's market capitalization. Although important, market cap isn't the firm's "worth". Instead, a company's "worth" is usually considered its break-apart value, typically its net tangible asset value (book value).
DNA's book value was 57 cents per share in June 2016, and is estimated to be worth 61 cents in 2017. In short, the market (as usual) is swinging its pendulum far from the firm's worth.
- Forums
- ASX - By Stock
- Time to buy DNA!
"the reality is the entire company is now worth significantly...
Featured News
Add DNA (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
-0.003(10.3%) |
Mkt cap ! $32.12M |
Open | High | Low | Value | Volume |
2.8¢ | 3.0¢ | 2.6¢ | $6.711K | 245.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 334999 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 131526 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 334999 | 0.026 |
3 | 386611 | 0.025 |
1 | 320000 | 0.024 |
2 | 100001 | 0.021 |
1 | 100099 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 131526 | 3 |
0.031 | 499883 | 2 |
0.032 | 500000 | 1 |
0.033 | 305891 | 1 |
0.034 | 237420 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
DNA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online